Canada· CA-DIN-02237450
SANDOZ D-FORTE
A ergocalciferol product containing vitamin d2, registered in Canada by SANDOZ CANADA INCORPORATED. The same ATC class is registered in 7 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Ergocalciferol is registered in 7 of 19 countries.
Countries holding a registration under ATC A11CC01 (ergocalciferol), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 5 of them publish a price we can compare per daily dose
Ergocalciferol · ATC A11CC01
7 / 19 countries
- Canada
- Czechiaprice
- Finlandprice
- Franceprice
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- VITAMIN D2
- Manufacturer
- SANDOZ CANADA INCORPORATED
- Country
- Canada (CA)
- ATC code
- A11CC01
- ATC class
- Ergocalciferol
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
68 interactions on record for ergocalciferol.
Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ergocalciferol · interactions on record
68 records
- 10 severe
- 56 moderate
- 2 minor
Most severe, free to view
- DihydrotachysterolA11CC02severe
- CalcitriolA11CC04severe
- ColecalciferolA11CC05severe
- CalcifediolA11CC06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ergocalciferol in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAacErgo 10,000unit tabletsEssential-Healthcare Ltd
- United StatesErgocalciferolChartwell RX, LLC
- FranceSTEROGYL 15 "A" 600 000 UI/1,5 ml, solution buvable en ampouleDESMA PHARMA
- BelgiumVitalipid Novum AdultFresenius Kabi
- FinlandDevitolOrion Corporation
- CzechiaCALCIFEROL BBPBB Pharma a.s., Praha
- NorwaySterogylDB Pharma
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Czechia · Calciferol Bbp
- France · Sterogyl, Sterogyl 15 "a"
- United Kingdom (Northern Ireland) · Ergocalciferol Rph Pharmaceuticals
- Slovakia · Calciferol Bbp
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/61d3e623-d4dc-4ad0-b82b-3c1d91e8729d GET /v1/drugs/61d3e623-d4dc-4ad0-b82b-3c1d91e8729d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02237450",
"form": "CAPSULE",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "A11CC01",
"schedule": [
"Prescription"
],
"drug_code": "60784",
"strengths": [
"50000 UNIT"
],
"ahfs_class": null,
"substances": [
"VITAMIN D2"
],
"product_categorization": null
}See everything about ergocalciferol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.